Overpromising AI capabilities to hospital stakeholders—now there’s a mistake healthcare AI enthusiasts have been known to make.

For the study, researchers had five diabetes specialists judge precision AI tools developed from a large, longitudinal dataset of patients’ individually expressed needs. 

Local investigative reporters have uncovered details on a scheme in which patients housed at a seedy motel received treatment for drug abuse as part of a massive Medicare fraud operation. 

The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.

The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients. 

Lawsuits filed against the Alabama Medical Cannabis Commission claim the agency has failed to develop the necessary database to license and certify providers in the state, effectively making medical cannabis inaccessible. The law allowing for medical marijuana use passed in 2021. 

The study's authors reviewed CCTA imaging results taken before and after radiotherapy, evaluating each image for signs of coronary calcification and inflammation. 

Patient outcomes do not appear to be negatively impacted by these risks, researchers noted. The new data were presented at Heart Rhythm 2025 and published in JACC: Clinical Electrophysiology.